Health
BioMérieux SARS-CoV-2 Serology Tests Granted FDA Emergency Use Authorization – HospiMedica
BioMérieux’s (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.
BioMérieuxs (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.The FDA has granted EUA to BioMérieuxs VIDAS SARS-COV-2 IgM and VIDAS SARS-COV-2 IgG automated qualitative assays which rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2. With the same protocols to differentiate IgM and IgG results, the VIDAS SARS-COV-2 IgM detects IgM specific for SARS-C…
-
Noosa News20 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News18 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News19 hours agoGood character references restricted in rape cases in Queensland